These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 37596842

  • 1. RB1 loss in the mesenchymal component of onychomatricoma.
    Liu Y, Zou D, Huang Q, Wang L.
    J Cutan Pathol; 2023 Dec; 50(12):1094-1098. PubMed ID: 37596842
    [Abstract] [Full Text] [Related]

  • 2. Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
    Perrin C, Pedeutour F, Coutts M, Ambrosetti D, Dadone-Montaudié B.
    Histopathology; 2023 Apr; 82(5):767-778. PubMed ID: 36647795
    [Abstract] [Full Text] [Related]

  • 3. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions.
    Agaimy A, Michal M, Giedl J, Hadravsky L, Michal M.
    Hum Pathol; 2017 Feb; 60():192-198. PubMed ID: 27825811
    [Abstract] [Full Text] [Related]

  • 4. Onychomatricoma: genome-wide analyses of a rare nail matrix tumor.
    Cañueto J, Santos-Briz Á, García JL, Robledo C, Unamuno P.
    J Am Acad Dermatol; 2011 Mar; 64(3):573-8, 578.e1. PubMed ID: 20691500
    [Abstract] [Full Text] [Related]

  • 5. Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker.
    Motanagh S, Bridge JA, Linos K.
    J Cutan Pathol; 2021 Feb; 48(2):295-301. PubMed ID: 32524651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The onychomatricoma: additional histologic criteria and immunohistochemical study.
    Perrin C, Baran R, Pisani A, Ortonne JP, Michiels JF.
    Am J Dermatopathol; 2002 Jun; 24(3):199-203. PubMed ID: 12140434
    [Abstract] [Full Text] [Related]

  • 12. Fibroepithelial Stromal Polyp of the Vulvovaginal Region as Part of the RB1 Family of Tumors: Friend or Foe?
    Cordier F, Van Roy N, Matthys B, De Paepe P, Van de Vijver K, Van Dorpe J, Creytens D.
    Int J Gynecol Pathol; 2024 May 01; 43(3):215-220. PubMed ID: 37922949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nail bed onychomatricoma.
    Wang L, Gao T, Wang G.
    J Cutan Pathol; 2014 Oct 01; 41(10):783-6. PubMed ID: 25039855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proliferating Onychomatricoma. Clinical, Dermoscopical, and Pathologic Features of Onychomatricoma New Variant Resembling Onycholemmal/Squamous Cell Carcinoma.
    Perrin C, Ambrosetti D, Balme B, Thomas L.
    Am J Dermatopathol; 2020 Nov 01; 42(11):827-834. PubMed ID: 32271204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.